Evidence map›Paper›PMID 37760565›Full record

ArticleCancers2023

Characterization of an

Atul Ranjan, Elizabeth A Thoenen, Atsushi Kaida, Stephanie Wood, Terry Van Dyke, Tomoo Iwakuma

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 71% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Atul RanjanDepartment of Pediatrics, Children's Mercy Research Institute, Kansas City, MO 64108, USA.
Elizabeth A ThoenenDepartment of Pediatrics, Children's Mercy Research Institute, Kansas City, MO 64108, USA.
Atsushi KaidaDepartment of Cancer Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA.ORCID 0000-0001-5891-4348
Stephanie WoodDepartment of Pathology & Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Terry Van DykePath Forward Solutions, LLC, Frederick, MD 21701, USA.
Tomoo IwakumaDepartment of Pediatrics, Children's Mercy Research Institute, Kansas City, MO 64108, USA.ORCID 0000-0001-7249-7958
Mercy Research · USThe University of Kansas Cancer Center · USUniversity of Kansas Medical Center · US

Funding

Transgenic & Gene-Targeting Shared ResourceP30CA168524 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI ROY A. JENSEN · 2012 to 2026
$40.1M
Control of mutant p53 stability via the mevalonate pathway-DNAJA1 axisR01CA214916 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI IWAKUMA, TOMOO · 2018 to 2022
$1.8M
The role of MDM2-MTBP axis in cancer metastasisR01CA174735 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI IWAKUMA, TOMOO · 2014 to 2018
$1.6M
NCI NIH HHS P30 CA168524NCI NIH HHS R01 CA174735NCI NIH HHS R01 CA214916
6 · The paper itself

Abstract

MTBP is implicated in cell cycle progression, DNA replication, and cancer metastasis. However, the function of MTBP remains enigmatic and is dependent on cellular contexts and its cellular localization. To understand the in vivo physiological role of MTBP, it is important to generate

Indexed as

hypomorphic alleleliver cancerMDM2 binding proteinmigrationmouseMTBP

Identifiers

PMID37760565
PMCPMC10526184
OpenAlexW4386837873

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.